Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02364076
Title Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Georgetown University
Indications

thymic carcinoma

Therapies

Epacadostat + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.